Sofpironium Bromide Patent Expiration

Sofpironium Bromide was first introduced by Botanix Sb Inc in its drug Sofdra on Jun 18, 2024.


Sofpironium Bromide Patents

Given below is the list of patents protecting Sofpironium Bromide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sofdra US11566000 Crystalline form of sofpironium bromide and preparation method thereof May 22, 2040 Botanix Sb
Sofdra US11584715 Crystalline form of sofpironium bromide and preparation method thereof May 22, 2040 Botanix Sb
Sofdra US11123325 Formulation for soft anticholinergic analogs Jul 20, 2037 Botanix Sb
Sofdra US10947192 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US10952990 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US10959983 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US10961191 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US11026919 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US11034652 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US11052067 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US11084788 Formulation for soft anticholinergic analogs May 22, 2034 Botanix Sb
Sofdra US10383846 Method of dosing and use of soft anticholinergic esters Mar 14, 2034 Botanix Sb
Sofdra US9220707 Method of dosing and use of soft anticholinergic esters Mar 14, 2034 Botanix Sb
Sofdra US9492429 Method of dosing and use of soft anticholinergic esters Mar 14, 2034 Botanix Sb
Sofdra US9895350 Method of dosing and use of soft anticholinergic esters Mar 14, 2034 Botanix Sb
Sofdra US8147809 Soft anticholinergic esters Mar 26, 2027 Botanix Sb
Sofdra US8628759 Soft anticholinergic esters Nov 13, 2026 Botanix Sb



Sofpironium Bromide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List